My Library

University LibraryCatalogue

     
Limit search to items available for borrowing or consultation
 
Look for full text

Search Discovery

Search Trove

Add record to RefWorks

Cover Art
PRINTED BOOKS
Author Green, Michael D., 1950-

Title Bendectin and birth defects : the challenges of mass toxic substances litigation / Michael D. Green.

Published Philadelphia : University of Pennsylvania Press, [1996]
©1996

Copies

Location Call No. Status
 UniM Law  KN 39 P6 G1 GREE    AVAILABLE
Physical description xiii, 368 pages ; 24 cm
Bibliography Includes bibliographical references (pages [353]-359) and index.
Contents 1. A Birth Defect Child Is Born -- 2. Locating Bendectin Within the Mass Toxic Landscape -- 3. The Science of Determining Toxic Causation -- 4. The Food and Drug Administration -- 5. The Wm. S. Merrell Company -- 6. A Mother's Quest -- 7. The Mekdeci Case -- 8. The Unraveling of Mekdeci -- 9. The Proliferation of Bendectin Litigation -- 10. Litigating a Multidistrict Case -- 11. The Withdrawal of Bendectin -- 12. Forging a Mass Toxic Substances Trial -- 13. The Settlement and Unsettlement of MDL-486 -- 14. The MDL-486 Trial -- 15. Aggregative Procedure in Mass Toxic Substances Litigation -- 16. The Third Phase of Bendectin Litigation: Oxendine Richardson, and the Individual Trials -- 17. The Legacy of Bendectin for Toxic Causation Law -- 18. The Lessons and Non-Lessons of Bendectin Litigation.
Summary Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation.
Subject Products liability -- Drugs -- United States.
Toxic torts -- United States.
Complex litigation -- United States.
Bendectin (Trademark) -- Toxicology.
Abnormalities, Human.
ISBN 0812232577 (alk. paper)
0812232577